These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28265769)

  • 21. Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways.
    Liao S; Xia J; Chen Z; Zhang S; Ahmad A; Miele L; Sarkar FH; Wang Z
    J Cell Biochem; 2011 Apr; 112(4):1055-65. PubMed ID: 21308734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
    Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
    Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
    Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
    Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
    Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
    Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
    Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.
    Rawat N; Alhamdani A; McAdam E; Cronin J; Eltahir Z; Lewis P; Griffiths P; Baxter JN; Jenkins GJ
    Clin Transl Oncol; 2012 Apr; 14(4):302-11. PubMed ID: 22484638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines.
    Nagai S; Kurimoto M; Washiyama K; Hirashima Y; Kumanishi T; Endo S
    J Neurooncol; 2005 Sep; 74(2):105-11. PubMed ID: 16193380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
    Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
    Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-κB Signaling Pathways.
    Korashy HM; Maayah ZH; Al Anazi FE; Alsaad AM; Alanazi IO; Belali OM; Al-Atawi FO; Alshamsan A
    Anticancer Res; 2017 Sep; 37(9):4899-4909. PubMed ID: 28870911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.
    Mukhopadhyay A; Bueso-Ramos C; Chatterjee D; Pantazis P; Aggarwal BB
    Oncogene; 2001 Nov; 20(52):7597-609. PubMed ID: 11753638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the proteasome as a promising therapeutic strategy in thyroid cancer.
    Wunderlich A; Arndt T; Fischer M; Roth S; Ramaswamy A; Greene BH; Brendel C; Hinterseher U; Bartsch DK; Hoffmann S
    J Surg Oncol; 2012 Mar; 105(4):357-64. PubMed ID: 22006286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor-kappa B inhibition can enhance apoptosis of differentiated thyroid cancer cells induced by 131I.
    Meng Z; Lou S; Tan J; Xu K; Jia Q; Zheng W
    PLoS One; 2012; 7(3):e33597. PubMed ID: 22438958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.
    Bauerle KT; Schweppe RE; Haugen BR
    Mol Cancer; 2010 May; 9():117. PubMed ID: 20492683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells.
    Zhang L; Cheng X; Gao Y; Bao J; Guan H; Lu R; Yu H; Xu Q; Sun Y
    Food Funct; 2016 Jan; 7(1):315-25. PubMed ID: 26442630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
    Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
    Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
    Wang YT; Liu HS; Su CL
    Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.